What is the initial work‑up for a newly diagnosed hypertensive patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Work-Up for Newly Diagnosed Hypertension

All newly diagnosed hypertensive patients require a standardized initial work-up consisting of basic laboratory tests, ECG, and cardiovascular risk stratification to guide treatment decisions and detect secondary causes. 1, 2

Confirm the Diagnosis First

Before proceeding with any work-up, confirm that hypertension is sustained and not a single elevated reading 1, 2, 3:

  • For office BP 120-159/70-99 mmHg: Confirm with out-of-office measurements (ambulatory or home BP monitoring) 1, 2
  • For office BP ≥160/100 mmHg: Confirm within 1 month using home or ambulatory measurements 1, 2
  • For BP ≥180/110 mmHg: Immediately exclude hypertensive emergency before routine work-up 1, 2, 3
  • Use validated automated devices with appropriate cuff size; take at least 2-3 measurements 4, 3

Mandatory Basic Laboratory Tests

Every newly diagnosed hypertensive patient requires these tests 1, 2:

Core Metabolic Panel

  • Serum electrolytes (sodium and potassium) 1, 2
  • Serum creatinine with estimated GFR to assess renal function 1, 2
  • Fasting blood glucose to detect diabetes 1, 2

Additional Essential Tests

  • Complete lipid profile (total cholesterol, LDL, HDL, triglycerides) 1, 2
  • Urinalysis (dipstick) 1, 2
  • Urine albumin-to-creatinine ratio (UACR) to detect early kidney damage 1, 2
  • Complete blood count 1, 4
  • Thyroid-stimulating hormone to detect thyroid disorders 1
  • 12-lead ECG to detect left ventricular hypertrophy, atrial fibrillation, and ischemic heart disease 1, 2

Essential Clinical Assessment

History Taking

Focus on these specific elements 1, 4:

  • Medication review: Current antihypertensives, adherence patterns, NSAIDs, steroids, sympathomimetics, cocaine, amphetamines 1, 4
  • Duration and severity: When hypertension was first detected, previous BP readings 1, 4
  • Symptoms suggesting secondary causes: Muscle cramps/weakness (hypokalemia from aldosteronism), palpitations/heat intolerance (hyperthyroidism), weight loss, frequent urination, easy bruising (Cushing's) 1, 4
  • Family history: Premature cardiovascular disease (men <55 years, women <65 years), hypertension, kidney disease 1
  • Cardiovascular risk factors: Smoking, diabetes, dyslipidemia, obesity 1

Physical Examination

Perform these specific assessments 1, 4:

  • BP measurement in both arms: Difference >10 mmHg suggests vascular disease 1
  • Orthostatic BP: Measure at 1 and 3 minutes after standing (abnormal if SBP drops ≥20 mmHg or DBP ≥10 mmHg) 1
  • Heart rate: Resting HR >80 bpm independently predicts cardiovascular events 1, 2
  • BMI and waist circumference: Target <94 cm in men, <80 cm in women 2
  • Cardiovascular exam: Apical impulse location (LVH), cardiac auscultation, peripheral pulses 4
  • Vascular exam: Abdominal bruits (renovascular disease), carotid bruits, delayed femoral pulses (coarctation) 1, 4
  • Endocrine stigmata: Cushingoid features, thyroid enlargement, neurofibromatosis 4
  • Fundoscopy: Especially if BP >180/110 mmHg to detect retinal hemorrhages or papilledema 1, 2

Cardiovascular Risk Stratification

Risk stratification determines treatment intensity and urgency 1, 2:

High-Risk Features Requiring Immediate Treatment

  • Established cardiovascular disease (prior MI, stroke, peripheral artery disease) 2
  • Diabetes mellitus 2
  • Chronic kidney disease (eGFR <60 mL/min/1.73m²) 2
  • Familial hypercholesterolemia 2

Additional Risk Factors to Document

  • Age: Men ≥55 years, women ≥65 years 1, 2
  • Male sex 1, 2
  • Dyslipidemia: Total cholesterol >190 mg/dL, LDL >115 mg/dL, HDL <40 mg/dL (men) or <46 mg/dL (women), triglycerides >150 mg/dL 1
  • Obesity: BMI ≥30 kg/m² or abdominal obesity (waist ≥102 cm men, ≥88 cm women) 1
  • Family history of premature CVD 1, 2

Risk Calculation

  • Use SCORE2 for ages 40-69 years or SCORE2-OP for ages ≥70 years 2
  • SCORE2/SCORE2-OP ≥10% indicates high risk requiring aggressive management 2

Optional Tests for Specific Indications

When to Assess for Hypertension-Mediated Organ Damage (HMOD)

Consider these tests in patients with low-to-moderate risk to reclassify risk level 2:

  • Echocardiography: When ECG shows abnormalities or cardiac symptoms present to assess LVH, systolic/diastolic dysfunction 1, 2
  • Carotid ultrasound: To detect atherosclerotic plaques when clinically indicated 2
  • Ankle-brachial index: For suspected peripheral artery disease 2
  • Brain CT/MRI: When neurologic symptoms present 2

When to Screen for Secondary Hypertension

Reserve secondary hypertension work-up for these specific scenarios 1, 4, 2:

  • Age <30 years with severe hypertension 4, 2
  • Sudden onset or rapid progression 4
  • Resistant hypertension (uncontrolled on 3 drugs including diuretic) 4, 2
  • Hypokalemia (spontaneous or diuretic-induced) 1
  • Abdominal bruit (renovascular disease) 1
  • Symptoms of pheochromocytoma (episodic headaches, palpitations, sweating) 1, 4

Specific Tests for Secondary Causes

  • Aldosterone-renin ratio: For primary aldosteronism (best done before starting interfering antihypertensives) 1, 2, 5
  • Plasma free metanephrines: For pheochromocytoma 1, 2
  • Late-night salivary cortisol or 24-hour urinary free cortisol: For Cushing syndrome 1, 2
  • Renal artery imaging (CT/MR angiography or Duplex ultrasound): For renovascular disease 1, 2
  • Renal ultrasound: For renal parenchymal disease 2

Common Pitfalls to Avoid

  • Do not perform extensive secondary hypertension screening in all patients—this is expensive and low-yield; reserve for specific clinical scenarios 5, 6
  • Do not skip out-of-office BP confirmation—white coat hypertension affects 15-30% of patients 1, 2
  • Do not forget orthostatic BP measurement in elderly, diabetic patients, or those on multiple medications—orthostatic hypotension predicts worse outcomes 1
  • Do not measure aldosterone-renin ratio while patient is on interfering drugs (ACE inhibitors, ARBs, diuretics, beta-blockers) without considering their effect on interpretation 5
  • Do not overlook medication and substance use—NSAIDs, steroids, cocaine, and amphetamines are common reversible causes 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hypertension Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hypertension Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Initial Workup of In-Hospital Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the best approach to manage a patient with uncontrolled hypertension, considering their past medical history, demographic information, and potential underlying causes such as kidney disease or sleep apnea?
Does the essential hypertension (I10) diagnosis code cover initial lab work including Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP), and Thyroid-Stimulating Hormone (TSH) tests?
What is the appropriate workup for a patient with elevated blood pressure?
What diagnostic tests are indicated for a 24-year-old patient newly diagnosed with hypertension?
What is the initial approach to work up a patient with hypertension in the hospital?
Why would a telemedicine patient have an inverted precordial (V) lead ECG strip?
What is the optimal first‑line pain management for a patient with acute traumatic brain injury?
How should olanzapine be initiated and titrated in an adult with schizophrenia or bipolar disorder, including dosing adjustments for elderly patients or those with hepatic impairment?
What is the most likely cause and appropriate management of a new lump in a lactating mother's right breast noticed during breastfeeding?
In an adult with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia who is on maximally tolerated statin therapy but has not achieved LDL‑cholesterol target, how long should treatment with a PCSK9 inhibitor (alirocumab or evolocumab) be continued?
In a lactating woman with a new breast lump, why is a mammogram not the preferred initial imaging study?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.